FDA has sent a new batch of warning letters to telehealth firms that allegedly made false and misleading claims about low-cost compounded versions of GLP-1 drugs, the popular class of weight-loss therapies marketed by Novo Nordisk (NVO
ET Pharma.com shall not be responsible for any damage caused to any person/organisation directly or indirectly)
Finally, this review outlines the current challenges facing MNMs and future directions, aiming to provide insights for subsequent research on the treatment of digestive system diseases
The pill must be swallowed whole and cannot be split, crushed, chewed, or dissolved
Trans-ethnic and Ancestry-Specific Blood-Cell Genetics in 746,667 Individuals from 5 Global Populations
In May 2022, tirzepatide was first authorized to treat T2DM in the United States